In the disc development phase an antimicrobial susceptibility test (AST) disc containing a novel compound is formulated. Additionally, methods for the assay of its contents are verified. Initial stress studies identify the most suitable candidate formulation for the production of stable investigational use only (IUO) AST discs, preliminary QC criteria are generated during this process.

Click here to view the mastpharma® flyer

  • Grid
  • List